BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12928372)

  • 1. CD4+ Th cells resembling regulatory T cells that inhibit chronic colitis differentiate in the absence of interactions between CD4 and class II MHC.
    Denning TL; Qi H; König R; Scott KG; Naganuma M; Ernst PB
    J Immunol; 2003 Sep; 171(5):2279-86. PubMed ID: 12928372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10.
    Annacker O; Pimenta-Araujo R; Burlen-Defranoux O; Barbosa TC; Cumano A; Bandeira A
    J Immunol; 2001 Mar; 166(5):3008-18. PubMed ID: 11207250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC-II-independent CD4+ T cells induce colitis in immunodeficient RAG-/- hosts.
    Trobonjaca Z; Leithäuser F; Möller P; Bluethmann H; Koezuka Y; MacDonald HR; Reimann J
    J Immunol; 2001 Mar; 166(6):3804-12. PubMed ID: 11238623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance.
    Shimoda M; Mmanywa F; Joshi SK; Li T; Miyake K; Pihkala J; Abbas JA; Koni PA
    J Immunol; 2006 Jun; 176(11):6503-11. PubMed ID: 16709807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
    Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th cells and Th2 responses can develop in the absence of MHC class II-CD4 interactions.
    Wack A; Corbella P; Harker N; Roderick K; Norton T; Williams K; Williams O; Kioussis D
    J Immunol; 1999 Aug; 163(3):1162-9. PubMed ID: 10415010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens.
    Zhou P; Borojevic R; Streutker C; Snider D; Liang H; Croitoru K
    J Immunol; 2004 Feb; 172(3):1515-23. PubMed ID: 14734729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II-independent CD25+ CD4+ CD8alpha beta+ alpha beta T cells attenuate CD4+ T cell-induced transfer colitis.
    Krajina T; Leithäuser F; Reimann J
    Eur J Immunol; 2004 Mar; 34(3):705-714. PubMed ID: 14991600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph Node Stromal Cell-Intrinsic MHC Class II Expression Promotes MHC Class I-Restricted CD8 T Cell Lineage Conversion to Regulatory CD4 T Cells.
    Honan AM; Vazquez EN; Chen Z
    J Immunol; 2021 Sep; 207(6):1530-1544. PubMed ID: 34408011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity.
    Bienvenu B; Martin B; Auffray C; Cordier C; Bécourt C; Lucas B
    J Immunol; 2005 Jul; 175(1):246-53. PubMed ID: 15972655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cells monospecific to ovalbumin produced by Escherichia coli can induce colitis upon transfer to BALB/c and SCID mice.
    Yoshida M; Watanabe T; Usui T; Matsunaga Y; Shirai Y; Yamori M; Itoh T; Habu S; Chiba T; Kita T; Wakatsuki Y
    Int Immunol; 2001 Dec; 13(12):1561-70. PubMed ID: 11717197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
    Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
    J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora.
    Cong Y; Weaver CT; Lazenby A; Elson CO
    J Immunol; 2002 Dec; 169(11):6112-9. PubMed ID: 12444113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
    Honey K; Forbush K; Jensen PE; Rudensky AY
    J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
    Uraushihara K; Kanai T; Ko K; Totsuka T; Makita S; Iiyama R; Nakamura T; Watanabe M
    J Immunol; 2003 Jul; 171(2):708-16. PubMed ID: 12847237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
    Nasreen M; Ueno T; Saito F; Takahama Y
    J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and function of CD4+ T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4.
    Gilfillan S; Shen X; König R
    J Immunol; 1998 Dec; 161(12):6629-37. PubMed ID: 9862691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.